PentostatinFDA Approved: * August 7, 2007
Pharm Company: * BEDFORD LABS
Pentostatin (or deoxycoformycin, trade name Nipent, manufactured by SuperGen) is an anticancer chemotherapeutic drug. Mechanism It is classified as a purine analog, which is a type of antimetabolite. It mimics the nucleoside adenosine and thus inhibits the enzyme adenosine deaminase, interfering with the cell's ability to process DNA. Cancer cells generally divide more often than healthy cells; DNA is highly involved in cell division (mitosis) and drug... [wikipedia]* May have multiple approval dates, manufacturers, or labelers.
Related BrandsDrugs with the same active ingredients
Pentostatin/ Cytoxin treatment
Why has there been , so to speak, no recent, say after 2010, discussion of treatment of Waldenstroms with Pentostatin/Cy...1 REPLY